Evidence-Based Research
GLP-1 Research
You Can Trust
Independent analysis of GLP-1 medications, clinical studies, and treatment comparisons — AI-assisted, human-reviewed, and always transparent.
Latest Research
Top 10 Exercise Strategies for GLP-1 Users Compared: Strength, Cardio, Mobility (2026)
Compared: 10 exercise strategies for GLP-1 users. Muscle preservation, time/week, intensity, and verdict for each.
May 24, 2026listicleTop 10 GLP-1 & GIP/GLP-1 Medications Compared: Wegovy, Zepbound, Retatrutide (2026)
Compared: 10 GLP-1 medications from Wegovy to Retatrutide. FDA status, dosing, weight loss, cost, and verdict for each.
May 24, 2026articleonions stimulate glp-1
Onions stimulate GLP-1 modestly through quercetin and gut hormones. See 2026 trial data, dose, and how onions compare to Zepbound, Wegovy, and Ozempic.
May 5, 2026guideGLP-1 Stacking with Cagrilintide: What the Phase 3 Data Shows in 2026
CagriSema phase 3 data: 20.4% weight loss, FDA review in 2026. What stacking cagrilintide with semaglutide actually shows.
Apr 30, 2026By the Numbers
Patients on GLP-1 medications
Max weight loss (tirzepatide)
Avg. monthly cost without insurance
Insurance coverage rate
Stay Updated
Weekly research summaries, new study alerts, and treatment updates. Free forever — no spam, unsubscribe anytime.